期刊文献+

P-糖蛋白与P53蛋白在乳腺癌中的表达及意义 被引量:3

The Expression of P-glycoprotein and P53 Protein in Breast Cancer and the Significance
下载PDF
导出
摘要 目的探讨P糖蛋白(P-gp)和P53蛋白在乳腺癌中的表达及意义。方法 53例术前未进行化疗的乳腺癌标本经福尔马林固定、石蜡包埋后,用免疫组织化学方法检测乳腺癌组织中的多药耐药蛋白P-gp和P53的表达情况。结果 P-gp和P53在乳腺癌中的表达分别为49%(26/53)和51%(27/53)。P-gp表达与乳腺癌患者的年龄、组织学类型和淋巴结转移状况无关(P>0.05),而P53蛋白的表达除与年龄有关外(P<0.05),与组织学类型和淋巴结转移无关(P>0.05),P-gp在P53阳性病例中的表达明显高于P53阴性者(P<0.01)。结论免疫组织化学法检测P-gp、P53蛋白的表达对评估和指导乳腺癌化疗及预后具有一定的临床价值。 Objective To investigate the expression of P-glycoprotein (P-gp) and P53 protein in breast cancer and the significance. Methods Tumor samples from 53 patients with breast cancer, receiving no chemotherapy before surgery, were fixed in formalin and em-bedded with paraffin, and then the expression of P-gp and P53 protein was detected by immunohistochemistry. Results The expression of P-gp and P53 protein in breast cancer reached 49%(26/53) ad 51%(27/53) respectively;the expression of P-gp was not correlated with the age of the patients, histological types and lymph node metastasis (P〉0.05) while the expression of P53 protein was not correlat-ed with the histological types and lymph node metastasis (P〉0.05)but with the age of the patients (P〈0.05);the expression of P-gp in P53 positive cases was much higher than that in P53 negative cases (P〈0.01). Conclusions The detection of the expressions of P-gp and P53 protein by immunohistochemistry is of certain clinical value in evaluating the effect of chemotherapy for breast cancer and the prog-nosis.
出处 《西南军医》 2014年第5期489-491,共3页 Journal of Military Surgeon in Southwest China
关键词 乳腺癌 P53蛋白 免疫组织化学 breast cancer P-glycoprotein (P-gp) P53 proten immunohistochemistry
  • 相关文献

参考文献1

二级参考文献10

  • 1Oka M,Fukuda M,Sakamoto A,et al.The clinical role of MDR1 gene expression in human lung cancer[].Anticancer Research.1997
  • 2Angelis PD,Stokke T,Smedshammer L,et al.P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo[].British Journal of Cancer.1995
  • 3Ota E,Abe Y,Oshika Y,et al.Expression of the multidrug resistance-associated protein(MRP) gene in non-small cell lung cancer[].British Journal of Cancer.1995
  • 4Morkve O,Laerum OD.Flow cytometric measurement of p53 protein expression and DNA content in paraffin-embedded tissue from bronchial carcinomas[].Cytometry.1991
  • 5Futscher BW,Abbaszadegan MR,Domann F,et al.Analysis of MRP mRNA in mitoxantrone-selected, multidrug resistant human tumor cells[].Biochemical Pharmacology.1994
  • 6Abe Y,Ohnishi Y,Yoshimura M,et al.P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo[].British Journal of Cancer.1996
  • 7Beer TW,Rowlands DC,Crocker J.Detection of the multidrug resistance marker P-glycoprotein by immunohistochemistry in malignant lung tumours[].Thorax.1996
  • 8Bodey B,Bodey BJR,Groger AM,et al.Immunocytochemical detection of the P170 multidrug resistance (MDR) and the p53 tumor suppressor gene proteins in human breast cancer cells: clinical and therapeutical significance[].Anticancer Research.1997
  • 9Scotlandi K,Serra M,Nicoletti G,et al.Multidrug resistance and malignancy in human osteosarcoma[].Cancer Research.1996
  • 10Zastawny RL,Salvino R,Chen J,et al.The core promoter region of the Pglycoprotein gene is sufficient to confer differential responsiveness to wildtype and mutant p53[].Oncegene.1993

同被引文献38

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部